Headlines
-
Blackmores profit up 20%
Friday | Feb 23 2018BLACKMORES has reported overall group revenue was boosted 9% to $287m for the six months to 31 Dec primarily from "consistent sales growth with improved profitability" and resulting in net profit after tax for shareholders at $34m, up 20% on the previous corresponding period (PD Breaking News yesterday).
-
MCC on cautionary RACP
Friday | Feb 23 2018AUSTRALIA'S peak medical cannabis industry group, the Medical Cannabis Council (MCC), today said the Royal Australian College of Physicians' (RACP) reticence towards medical cannabis "disregards patient and international experience".
-
‘War’ not ‘jaw’ over code
Thursday | Feb 22 2018IN AN unflinchingly direct letter to the Department of Health First Assistant Secretary Ross Hawkins, Friends of Science advocate and public health protagonist Associate Professor Ken Harvey of Monash University has called for "respect and constructive outcomes".
-
Community pharmacy tick
Thursday | Feb 22 2018THE Australian "tried and trusted community pharmacy model" received a shot in the arm with the passage through Federal Parliament last week of amendments that removed the sunset clause on the Pharmacy Location Rules (PD 14 Feb), Pharmacy Guild of Australia executive director David Quilty writes.
-
CW nets major partnership
Wednesday | Feb 21 2018AUSTRALIAN pharmacy discount retail group Chemist Warehouse has again linked with Beach Netball ("It's netball, but not as you know it") as a major partner and is gearing up to support the upcoming 2018 series across the country.
-
EBOS H1 earnings up 15.6%
Wednesday | Feb 21 2018ASX-LISTED marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products EBOS, has announced a record interim unaudited net profit of $76.7m for the six months to 31 Dec 2017, with EBITDA up 15.6% and net profit after tax up 11.5%.
-
Gabapentinoid abuse up
Wednesday | Feb 21 2018THE US Food and Drug Administration (FDA) is actively looking into the potential misuse and abuse of gabapentinoids, a class of drugs that includes Pfizer's Neurontin (gabapentin) and Lyrica (pregabalin), which have been approved to treat a number of conditions such as postherpetic neuralgia, fibromyalgia and neuropathic pain.
-
TGA CM advertising debate
Tuesday | Feb 20 2018BOTH science and civil society organisations have continued to raise a storm over the passage through parliament the 2017 Measures No.1 Bill, according to an MJA Insight article.
-
Pharmacy training offers
Tuesday | Feb 20 2018THE Pharmaceutical Society of Australia (PSA) has announced it has resumed training for community pharmacy qualifications across Australia for pharmacy staff, including dispensary and pharmacy assistants.
-
‘Pharmacy first’ says NHS
Monday | Feb 19 2018PARENTS of young children with minor illnesses should take them to pharmacies rather than GPs or an A&E, a new NHS England campaign says, reports the BBC.